Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Longterm (52-week) results of a phase III randomized, controlled trial of apremilast in patients with psoriatic arthritis.
Journal: The Journal of rheumatology
Published: January 17, 2015
Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor.
Journal: Annals of the rheumatic diseases
Published: March 06, 2014
A trial evaluating gradual- or immediate-switch strategies from risperidone, olanzapine, or aripiprazole to iloperidone in patients with schizophrenia.
Journal: Schizophrenia research
Published: May 08, 2013
A thorough QTc study of 3 doses of iloperidone including metabolic inhibition via CYP2D6 and/or CYP3A4 and a comparison to quetiapine and ziprasidone.
Journal: Journal of clinical psychopharmacology
Published: January 02, 2013
A global measure to assess switching antipsychotic medications in the treatment of schizophrenia.
Journal: Human psychopharmacology
Published: October 16, 2011
Showing 1-5 of 5
Last Updated: 09/26/2026